Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 49% year on year to $1.02 billion. Guidance for next quarter’s revenue was optimistic at $977.5 million at the midpoint, 2.1% above analysts’ estimates. Its GAAP profit of $0.07 per share was significantly above analysts’ consensus estimates.
Health insurance company Alignment Healthcare (NASDAQ:ALHC)
will be announcing earnings results this Wednesday after market hours. Here’s what investors should know.
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC)
jumped 3.2% in the afternoon session after the company announced a significant legal victory against the Centers for Medicare & Medicaid Services (CMS), which boosted its Arizona HMO plan's 2025 star rating. The federal court ruling, announced today, increases the plan's rating from 3.5 to 4 stars. This is a crucial development for the Medicare Advantage provider, as plans rated 4 stars or higher qualify for bonus payments from CMS. As a result of the decision, 100% of Alignment's members are now enrolled in plans with a 4-star rating or higher. The company stated it will reinvest the bonus payments to enhance member benefits and services. This legal win not only has positive financial implications but also validates the quality of care the company provides, potentially attracting more members and increasing its market share in the competitive Medicare Advantage space.
Over the past six months, Alignment Healthcare has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $13.61, representing a healthy 16.3% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Unprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Alignment Healthcare (NASDAQ:ALHC) and its peers.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Health insurance company Alignment Healthcare (NASDAQ:ALHC) announced better-than-expected revenue in Q1 CY2025, with sales up 47.5% year on year to $926.9 million. The company expects next quarter’s revenue to be around $957.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates.
Health insurance company Alignment Healthcare (NASDAQ:ALHC) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 47.5% year on year to $926.9 million. Guidance for next quarter’s revenue was better than expected at $957.5 million at the midpoint, 1.3% above analysts’ estimates. Its GAAP loss of $0.05 per share was 59.7% above analysts’ consensus estimates.
